Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy
Colorectal NeoplasmsThis is an observational study in a clinical setting to estimate the prevalence of advanced colorectal neoplasia (ACN) at colonoscopy in those with a history of low or high risk polyps or a family history of CRC/polyps and to verify the test performance characteristics of FIT in these populations. Using this information, a risk prediction model will be developed to help guide the choice between FIT and colonoscopy in the ongoing surveillance or screening of patients.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 to 74
Critères de participation
Inclusion Criteria:
1. Men or women age ≤ 74 years of age.
2. At least one risk factor for CRC that would generally lead to colonoscopy screening:
1. Personal history of low risk polyps
2. Personal history of high risk polyps
3. Family history of CRC or polyps
Exclusion Criteria:
1. Known acromegaly, cystic fibrosis or high risk profession (firefighter)
2. Referred for colonoscopy due to a positive fecal immunochemical test or CT colonography
3. Known or suspected gene carrier for a familial cancer syndrome.
4. Does not meet medical criteria for colonoscopy at the CCSC.
5. Colonoscopy within the previous 30 months
6. Unable to provide written informed consent or complete questionnaires due to language barrier or other reasons.
Lieu de l'étude
Forzani & Macphail Colon Cancer Screening Centre, University of Calgary
Forzani & Macphail Colon Cancer Screening Centre, University of CalgaryCalgary, Alberta
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- University of Calgary
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT05396560